1-20 of 23
Authors: Alexa Christ
Journal Article
INNV-25. ASSESSING SLEEP AND CIRCADIAN RHYTHMS IN PRIMARY BRAIN TUMORS PATIENTS: AN OBSERVATIONAL STUDY
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii146–vii147, https://doi.org/10.1093/neuonc/noac209.565
Published: 14 November 2022
Journal Article
INNV-21. FEASIBILITY OF A VIRTUAL REALITY (VR) INTERVENTION TARGETING DISTRESS AND ANXIETY IN PRIMARY BRAIN TUMOR (PBT) PATIENTS AT THE TIME OF NEUROIMAGING: INTERIM ANALYSIS OF A PHASE 2 CLINICAL TRIAL
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii145–vii146, https://doi.org/10.1093/neuonc/noac209.561
Published: 14 November 2022
Journal Article
BIOM-46. EXPLORING CLINICAL AND PATHOLOGIC CHARACTERISTICS IN GLIOBLASTOMA LONG -TERM SURVIVORS (LTS) VERSUS SHORT-TERM SURVIVORS (STS)
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii14–vii15, https://doi.org/10.1093/neuonc/noac209.056
Published: 14 November 2022
Journal Article
NIMG-101. COMPARISON OF PRE-SURGICAL MRI FINDINGS FROM LONG-TERM (≥ 3 YRS) VERSUS SHORT-TERM (< 3 YRS) GLIOBLASTOMA SURVIVORS: A BLINDED, CASE-CONTROL REVIEW
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii188, https://doi.org/10.1093/neuonc/noac209.719
Published: 14 November 2022
Journal Article
INNV-32. COMPARING THE MONTREAL COGNITIVE ASSESSMENT (MOCA) FULL AND 5-MINUTE PROTOCOLS IN MILD COGNITIVE IMPAIRMENT SCREENING OF ADULT CNS TUMOR PATIENTS
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii148, https://doi.org/10.1093/neuonc/noac209.572
Published: 14 November 2022
Journal Article
NCOG-40. UTILITY OF THE SEIZURE CONTROL COMPOSITE INDEX (RANO-SCCI) IN EVALUATING SEIZURES IN CNS TUMOR PATIENTS
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii206, https://doi.org/10.1093/neuonc/noac209.791
Published: 14 November 2022
Journal Article
NCOG-39. DISCOVERY OF CLINICAL AND DEMOGRAPHIC DETERMINANTS OF SYMPTOM BURDEN IN PRIMARY BRAIN TUMOR PATIENTS USING NETWORK ANALYSIS AND UNSUPERVISED CLUSTERING
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii205–vii206, https://doi.org/10.1093/neuonc/noac209.790
Published: 14 November 2022
Journal Article
NCOG-33. IDENTIFYING SELF-EFFICACY DIFFERENCES IN ADULT RARE CNS PATIENTS PARTICIPATING IN A NOVEL WEB-BASED NATURAL HISTORY
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii204, https://doi.org/10.1093/neuonc/noac209.784
Published: 14 November 2022
Journal Article
PATH-08. PROGNOSTIC IMPLICATIONS FROM LONG-TERM SURVIVORS (LTS) OF GLIOBLASTOMA
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi116, https://doi.org/10.1093/neuonc/noab196.460
Published: 12 November 2021
Journal Article
NCOG-23. PATIENT-REPORTED SYMPTOM BURDEN AND INTERFERENCE: A COMPARISON BETWEEN COVID-19 PANDEMIC YEAR AND NORMATIVE DATA IN PATIENTS WITH CENTRAL NERVOUS SYSTEM (CNS) TUMORS
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Pages vi156–vi157, https://doi.org/10.1093/neuonc/noab196.614
Published: 12 November 2021
Journal Article
QOLP-37. MOOD DISTURBANCE IN PATIENTS WITH CENTRAL NERVOUS SYSTEM (CNS) TUMORS DURING THE COVID-19 PANDEMIC
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi191, https://doi.org/10.1093/neuonc/noab196.757
Published: 12 November 2021
Journal Article
NCOG-43. RELATIONSHIPS BETWEEN MOOD DISTURBANCE, SYMPTOM INTERFERENCE, AND DISEASE PROGRESSION IN GLIOMA PATIENTS
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi161, https://doi.org/10.1093/neuonc/noab196.633
Published: 12 November 2021
Journal Article
NCOG-16. RELEVANCE OF GERIATRIC ASSESSMENT FOR PRIMARY BRAIN TUMOR PATIENTS: IMPLICATIONS FOR RESEARCH AND CARE
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi155, https://doi.org/10.1093/neuonc/noab196.607
Published: 12 November 2021
Journal Article
CTIM-32. IMMUNE CHECKPOINT INHIBITOR NIVOLUMAB IN PEOPLE WITH RECURRENT SELECT RARE CNS CANCERS: RESULTS OF INTERIM ANALYSIS IN A HEAVILY PRETREATED COHORT
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Pages vi57–vi58, https://doi.org/10.1093/neuonc/noab196.224
Published: 12 November 2021
Journal Article
NCOG-44. FEASIBILITY AND UTILITY OF THE MONTREAL COGNITIVE ASSESSMENT IN ROUTINE CLINICAL EXAMS AND TELEHEALTH VISITS IN NEURO-ONCOLOGY
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Pages vi161–vi162, https://doi.org/10.1093/neuonc/noab196.634
Published: 12 November 2021
Journal Article
NCOG-18. RELATIONSHIP BETWEEN RANO-PRO WORKING GROUP STANDARDIZED PRIORITY CONSTRUCTS AND DISEASE PROGRESSION AMONG MALIGNANT GLIOMA PATIENTS AS MEASURED THROUGH CLINICAL OUTCOMES ASSESSMENTS
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Pages vi155–vi156, https://doi.org/10.1093/neuonc/noab196.609
Published: 12 November 2021
Journal Article
QOLP-19. FINANCIAL TOXICITY AND DISTRESS DURING THE COVID-19 PANDEMIC IN PEOPLE LIVING WITH PRIMARY BRAIN TUMORS
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi187, https://doi.org/10.1093/neuonc/noab196.740
Published: 12 November 2021
Journal Article
NCOG-42. SYMPTOM ONSET TO TIME OF DIAGNOSIS IN PRIMARY CENTRAL NERVOUS SYSTEM TUMOR PATIENTS: A REVIEW OF FINDINGS FROM THE NOB-NHS
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi161, https://doi.org/10.1093/neuonc/noab196.632
Published: 12 November 2021
Journal Article
QOLP-23. EVALUATION OF FINANCIAL TOXICITY (FT) IN PEOPLE WITH RARE CENTRAL NERVOUS SYSTEM (CNS) TUMORS USING AN INNOVATIVE WEB-BASED STUDY DESIGN
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Pages vi187–vi188, https://doi.org/10.1093/neuonc/noab196.743
Published: 12 November 2021
Journal Article
NCOG-39. EXPLORING PATIENT REPORTED OUTCOMES (PROS) ACROSS ETHNORACIAL GROUPS IN PRIMARY BRAIN TUMOR (PBT) PATIENTS: DIFFERENCES IN THE ILLNESS EXPERIENCE
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi160, https://doi.org/10.1093/neuonc/noab196.629
Published: 12 November 2021
